U.S. Hospitality Stock News

Nutex Health has opened its 26th hospital and first Missouri location, Archview ER & Hospital in St. Louis, a 16,000-square-foot facility with 15 emergency beds, 3 inpatient suites, and full-service lab and advanced imaging available 24/7/365. This move extends Nutex Health’s micro-hospital footprint into a new state, underlining its focus on smaller, technology-equipped facilities aimed at convenient community care. We’ll now look at how this Missouri micro-hospital opening fits into Nutex...

AiRWA (YYAI) has quietly posted a strong 1 day jump of about 6% and a roughly 18% gain over the past week, even though the longer term chart still looks rough. See our latest analysis for AiRWA. Those sharp 1 day and 7 day share price returns sit against a brutal year to date share price return of about negative 98 percent and a similar one year total shareholder return. As a result, the latest bounce looks more like speculative momentum than a clear turnaround. If AiRWA’s volatility has your...

Celsius Holdings (CELH) has had a strong run lately, with the stock up about 18% over the past month and more than 60% this year, even after a choppy past 3 months. See our latest analysis for Celsius Holdings. That recent pop in Celsius Holdings comes after a more volatile stretch, but the stock still shows strong momentum overall, with a 64.41% year to date share price return and a 63.45% one year total shareholder return. If Celsius’s surge has you rethinking your watchlist, it might be a...

Expedia Group (EXPE) has been quietly climbing, with shares gaining around 15% over the past month and more than 50% over the past year, as investors reassess its travel recovery story. See our latest analysis for Expedia Group. The latest leg of Expedia Group's rally, with a roughly 33% 3 month share price return, has come as investors grow more confident in its steady post pandemic travel recovery and improving profitability, while a 52% one year total shareholder return signals that...

Earlier this month, TE Connectivity plc’s board declared a regular quarterly cash dividend of US$0.71 per ordinary share, payable on March 13, 2026, to shareholders of record as of February 20, 2026. At the same time, institutional commentary highlighted record net sales, operating margins, cash generation, and orders, underlining TE Connectivity’s role in AI, renewables, and electric grid hardening as a key earnings driver. We’ll now examine how TE Connectivity’s record operational...

If you are wondering whether Pfizer at around $25 a share is a value trap or a quiet opportunity, you are not alone. This article will walk through the case step by step. Despite a modest 0.4% gain over the last year, the stock is still down 41.4% over three years and 13.1% over five years. That tells us the market has drastically reset its expectations and may be mispricing the long term story. That reset has been driven by fading Covid related optimism and a tougher backdrop for big pharma...

Birkenstock Holding (BIRK) has quietly become a talking point again as the stock tries to claw back from a roughly 26% slide this year, despite double digit revenue and earnings growth. See our latest analysis for Birkenstock Holding. The pullback has come as investors reassess how much to pay for Birkenstock’s strong fundamentals. The roughly 26% year to date share price return loss contrasts against still solid growth and keeps the $42.45 share price in a consolidation zone where momentum...

Lowe’s Companies has been expanding its professional services arm through acquisitions such as Artisan Design Group and Foundation Building Materials in 2025, aiming to better serve contractors and offset weaker DIY trends and pressured margins. This shift, alongside a rising but still moderate level of short interest and a long record of dividend growth, highlights how Lowe’s is reshaping its business mix while facing competitive and debt-related constraints. We’ll now explore how Lowe’s...

Significant insider selling by President and COO Tanious Jubran at Savers Value Village (SVV), along with a new credit agreement, has put the thrifter’s balance sheet and leadership confidence under a sharper investor microscope. See our latest analysis for Savers Value Village. Against that backdrop, Savers Value Village’s 1 month share price return of 14.55 percent looks like a short term rebound within a more cautious trend. The year to date share price return of negative 7.89 percent and...

Wondering if PepsiCo at around $143 is a quietly attractive entry point, or just an expensive comfort stock you already know too well? The share price has drifted lower recently, with returns of -4.2% over the last week, -1.2% over the last month, and -4.3% year to date, even though the 5 year return still sits at a modest 13.8%. Recent headlines have focused on PepsiCo doubling down on its snacks and beverages portfolio, from expanding zero sugar offerings to rolling out new product...

SEALSQ (LAES) just teamed up with Airmod on an open source enabled middleware stack built around its secure DevKits, aiming to cut quantum resistant IoT device deployment timelines roughly in half. See our latest analysis for SEALSQ. Those moves land at an interesting moment for investors, with SEALSQ’s share price last closing at $4.16 and showing a 7 day share price return of 7.77 percent, but a year to date share price return of minus 52.02 percent and a 1 year total shareholder return of...

Upstart Holdings (UPST) is back in focus after Tech CU expanded its use of Upstart’s AI lending platform, adding personal loans now and planning auto refinance offerings in early 2026 through the Upstart Referral Network. See our latest analysis for Upstart Holdings. The Tech CU expansion comes as Upstart’s share price has rebounded, with a 7 day share price return of 7.04 percent and 30 day share price return of 23.58 percent. This comes even though the year to date share price return of...

Fifth Third Bancorp (FITB) has quietly put together a strong run, with the stock up about 14% over the past month and 16% in the past year, outpacing many regional bank peers. See our latest analysis for Fifth Third Bancorp. That 13.91% 1 month share price return, alongside a 16.15% 1 year total shareholder return, suggests momentum is building as investors warm to Fifth Third’s growth profile and risk outlook at around $48.22 per share. If strong regional bank performance has your attention,...

If you are looking at Vail Resorts and wondering whether the recent share price weakness has finally turned this into a bargain, you are not alone. The stock is trading around $139.66 after a choppy spell, down 10.7% over the last week but still up 3.4% over the past month, while longer term returns, such as a 20.3% drop year to date and a 23.1% slide over the last year, keep many investors cautious. Recently, investors have been focused on how Vail is navigating changing travel patterns and...

Alliant Energy has announced that long-serving executive David A. de Leon will retire in 2026 after 39 years, with Rebecca Cameron Valcq appointed President of Wisconsin Power and Light and Vice President of Alliant Energy and Interstate Power and Light, effective January 5, 2026. Valcq’s prior role as Chair of the Public Service Commission of Wisconsin gives Alliant Energy a leader with deep regulatory insight at the helm of a key subsidiary. We’ll now examine how Valcq’s regulatory...

Recent analyst commentary around Vaxcyte (PCVX) zeroed in on encouraging Phase 2 data for its VAX-31 pneumococcal vaccine, sharpening investor focus on how the program could reshape the company’s prospects as it heads into pivotal Phase 3 trials. See our latest analysis for Vaxcyte. Those upbeat VAX-31 data have arrived after a choppy stretch, with the share price at $47.65 and a 7 day share price return of 10.66 percent. This contrasts with a year to date share price return of negative 42.80...

Rocket Companies (RKT) has quietly kept climbing, and with the stock up roughly 79% this year, investors are asking whether the move still makes sense or if expectations are running ahead of reality. See our latest analysis for Rocket Companies. The recent run has been powered less by flashy headlines and more by shifting sentiment, as investors warm to Rocket Companies’ improving revenue trends and housing market resilience. A 79.26% year to date share price return and 209.54% three year...

Market context for Brookdale Senior Living Brookdale Senior Living (BKD) has quietly turned into a strong recovery story, with shares up more than 115% this year and roughly 300% over the past 3 years. See our latest analysis for Brookdale Senior Living. The latest leg of Brookdale’s move has seen a 90 day share price return of just over 30 percent, following a period of recent consolidation. This suggests momentum is still broadly constructive when viewed in the context of its multi year...

Globalstar (GSAT) has quietly delivered a strong run, almost doubling year to date and more than doubling over the past year. This performance is prompting investors to reconsider how the satellite operator is being valued. See our latest analysis for Globalstar. That surge has been driven less by a single headline and more by steadily improving sentiment, with an 82.54 percent 3 month share price return and a standout 1 year total shareholder return of 114.04 percent, signaling strong...

Plains All American Pipeline (PAA) is reshaping its portfolio with a $3.8 billion sale of Canadian NGL assets and a full buyout of the Epic Crude Oil Pipeline, sharpening its focus on steadier fee-based earnings and dividend growth. See our latest analysis for Plains All American Pipeline. These portfolio moves come after a steady run, with the share price at about $17.74 and a modest 30 day share price return of 3.26 percent, while the five year total shareholder return of 211.71 percent...

Gemini Space Station (GEMI) has quietly climbed in the past week, even as its stock remains deep in the red for the year, and that disconnect is exactly what has investors talking. See our latest analysis for Gemini Space Station. That recent 7 day share price return of 2.9 percent, and 30 day share price return of 5.6 percent, looks more like a tentative bounce than a true reversal when you set it against a brutal year to date share price return of roughly negative 64 percent at a last close...

Avantor (AVTR) has been grinding through a tough stretch, with the share price sliding over the past year even as revenue edges higher. That disconnect sets up an interesting value conversation for patient investors. See our latest analysis for Avantor. At around $11.28 per share, Avantor’s 1 year total shareholder return of roughly negative 47 percent tells you sentiment has been reset, and the slightly negative 3 month share price return suggests momentum is still fading, even as...

The catalyst here is clear: Cytokinetics (CYTK) just secured FDA approval for MYQORZO, its first commercial therapy for symptomatic obstructive hypertrophic cardiomyopathy, turning years of clinical work into a real revenue opportunity. See our latest analysis for Cytokinetics. Investors have been repositioning around that catalyst all year, with the 90 day share price return of 34.18 percent and a 1 year total shareholder return of 32.25 percent suggesting momentum is building rather than...

HF Sinclair (DINO) has had a choppy few months, with the stock sliding roughly 13% over the past month and 14% over the past 3 months, even after a strong year. See our latest analysis for HF Sinclair. The recent slide looks more like a breather than a breakdown, with the share price still up strongly year to date and a three year total shareholder return that remains positive, while the five year total shareholder return is particularly impressive. If HF Sinclair’s moves have you rethinking...